Thanks JPGuru. TGA a blow considering availability in other markets. I’ve unfortunately seen how quickly this cancer takes a life and the device is a good palliative care option especially for those who can’t travel o/s to see someone in palliative care. So it seems another trial required for TGA and presumably FDA, bar that HDE avenue. Approvals pathway and sales seems to be the SP catalysts …
OSL Price at posting:
4.6¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)